AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discovery

INTRODUCTION: The portfolio of novel targets to treat Alzheimer's disease (AD) has been enriched by the Accelerating Medicines Partnership Program for Alzheimer's Disease (AMP AD) program. METHODS: Publicly available resources, such as literature and databases, enabled a data‐driven effort...

Descripción completa

Detalles Bibliográficos
Autores principales: Potjewyd, Frances M., Annor‐Gyamfi, Joel K., Aubé, Jeffrey, Chu, Shaoyou, Conlon, Ivie L., Frankowski, Kevin J., Guduru, Shiva K. R., Hardy, Brian P., Hopkins, Megan D., Kinoshita, Chizuru, Kireev, Dmitri B., Mason, Emily R., Moerk, Charles T., Nwogbo, Felix, Pearce, Kenneth H., Richardson, Timothy I., Rogers, David A., Soni, Disha M., Stashko, Michael, Wang, Xiaodong, Wells, Carrow, Willson, Timothy M., Frye, Stephen V., Young, Jessica E., Axtman, Alison D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019904/
https://www.ncbi.nlm.nih.gov/pubmed/35475262
http://dx.doi.org/10.1002/trc2.12246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019904/
https://www.ncbi.nlm.nih.gov/pubmed/35475262
http://dx.doi.org/10.1002/trc2.12246

Ejemplares similares